Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
477 participants
OBSERVATIONAL
2014-05-31
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
NCT02113865
Prevalence of Liver Fibrosis and Progression of Liver Fibrosis
NCT01208376
Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients
NCT02093754
Prevalence of Advanced Fibrosis in Patients Living With HIV
NCT04066608
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
NCT04795219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of hepatocellular carcinoma according to American Association for the Study of Liver Diseases (AASLD) criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario de Valme
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicolás Merchante
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Orihuela
Orihuela, Alicante, Spain
Hospital Clínico Universitario de San Juan
Sant Joan d'Alacant, Alicante, Spain
Hospital Marina Baixa
Villajoyosa, Alicante, Spain
Hospital German Trias i Pujol
Badalona, Barcelona, Spain
Hospital General de Castellón
Castellon, Castellón, Spain
Hospital de La Linea
La Línea de la Concepción, Cádiz, Spain
Hospital Universitario de Donostia
San Sebastián, Guipúzcua, Spain
Hospital Universitario A Coruña
A Coruña, La Coruña, Spain
Hospital de San Pedro
Logroño, La Rioja, Spain
Hospital de Santa Lucía
Cartagena, Murcia, Spain
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain
Hospital de San Eloy
Barakaldo, Vizcaya, Spain
Hospital de Basurto
Basurto, Vizcaya, Spain
Hospital de Cruces
Bilbao, Vizcaya, Spain
Hospital de Galdakao
Galdakao, Vizcaya, Spain
Hospital General Universitario de Alicante
Alicante, , Spain
Hospital de Puerto Real
Cadiz, , Spain
Hospital Universitario Reina Sofía
Córdoba, , Spain
Hospital Universitario Virgen de las Nieves
Granada, , Spain
Complejo Hospitalario de Huelva
Huelva, , Spain
Complejo Hospitalario de Jaén
Jaén, , Spain
Hospital Universitario La Princesa
Madrid, , Spain
Hospital Regional Carlos Haya
Málaga, , Spain
Hospital Virgen de la Victoria
Málaga, , Spain
Hospital Universitario Arrixaca
Murcia, , Spain
Hospital Universitario Virgen Macarena
Seville, , Spain
Hospital Clínico de Valencia
Valencia, , Spain
Hospital General de Valencia
Valencia, , Spain
Hospital Universitario y Politécnico La Fe
Valencia, , Spain
Hospital de Txagorritxu
Vitoria-Gasteiz, Álava, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Merchante N, Merino E, Rodriguez-Arrondo F, Tural C, Munoz J, Delgado-Fernandez M, Jover F, Galindo MJ, Rivero A, Lopez-Aldeguer J, Aguirrebengoa K, Romero-Palacios A, Martinez E, Pineda JA. HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma. AIDS. 2014 Jan 2;28(1):41-7. doi: 10.1097/QAD.0000000000000005.
Merchante N, Merino E, Lopez-Aldeguer J, Jover F, Delgado-Fernandez M, Galindo MJ, Ortega E, Rivero A, Minguez C, Romero-Palacios A, Padilla S, Marquez-Solero M, Amador C, Rios-Villegas MJ, Tellez F, Portilla J, Pineda JA. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis. 2013 Jan;56(1):143-50. doi: 10.1093/cid/cis777. Epub 2012 Sep 5.
Merchante N, Ibarra S, Revollo B, Rodriguez-Arrondo F, Merino E, Delgado-Fernandez M, Montero-Alonso M, Tellez F, Galindo MJ, Rivero-Juarez A, Garcia MA, Minguez C, Romero-Palacios A, Garcia-Deltoro M, Pineda JA; GEHEP-002 Study Group. Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients. AIDS. 2017 Jan 2;31(1):89-95. doi: 10.1097/QAD.0000000000001293.
Merchante N, Rodriguez-Arrondo F, Revollo B, Merino E, Ibarra S, Galindo MJ, Montero M, Garcia-Deltoro M, Rivero-Juarez A, Tellez F, Delgado-Fernandez M, Rios-Villegas MJ, Garcia MA, Vera-Mendez FJ, Ojeda-Burgos G, Lopez-Ruz MA, Metola L, Omar M, Aleman-Valls MR, Aguirrebengoa K, Portu J, Raffo M, Macias J, Pineda JA; GEHEP-002 Study Group. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients. AIDS. 2018 Jul 17;32(11):1423-1430. doi: 10.1097/QAD.0000000000001809.
Pinato DJ, Allara E, Chen TY, Trevisani F, Minguez B, Zoli M, Harris M, Dalla Pria A, Merchante N, Platt H, Jain M, Caturelli E, Kikuchi L, Pineda J, Nelson M, Farinati F, Rapaccini GL, Aytaman A, Yin M, Tan CK, Bower M, Giannini EG, Brau N; Liver Cancer in HIV and ITA.LI.CA Study Groups. Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. J Clin Oncol. 2019 Feb 1;37(4):296-304. doi: 10.1200/JCO.18.00885. Epub 2018 Dec 18.
Merchante N, Figueruela B, Rodriguez-Fernandez M, Rodriguez-Arrondo F, Revollo B, Ibarra S, Galindo MJ, Merino E, Montero M, Tellez F, Garcia-Deltoro M, Rivero-Juarez A, Delgado-Fernandez M, Rios-Villegas MJ, Aguirrebengoa K, Garcia MA, Portu J, Vera-Mendez FJ, Villalobos M, Minguez C, De Los Santos I, Lopez-Ruz MA, Omar M, Galera C, Macias J, Pineda JA; GEHEP-002 Study Group. Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients. AIDS. 2019 Feb 1;33(2):269-278. doi: 10.1097/QAD.0000000000002065.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIS-VAC12
Identifier Type: OTHER
Identifier Source: secondary_id
GEHEP-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.